Ethanol septal reduction for symptomatic hypertrophic cardiomyopathy

被引：0
|
作者：
Lakkis, NM [1 ]
Kleiman, NS [1 ]
Killip, DM [1 ]
Spencer, WH [1 ]
机构：
[1] BAYLOR COLL MED,HOUSTON,TX 77030
来源：
CIRCULATION | 1997年 / 96卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1203 / 1203
页数：1
相关论文
共 50 条
  • [31] A novel hybrid approach to nonsurgical septal reduction in hypertrophic obstructive cardiomyopathy
    Bezgin, Tahir
    Celik, Aziz Inan
    Baytugan, Nart Zafer
    Cagdas, Metin
    POLISH HEART JOURNAL-KARDIOLOGIA POLSKA, 2024, 82 (10): : 1013 - 1014
  • [32] Sex Differences in the Outcomes of Septal Reduction Therapies for Obstructive Hypertrophic Cardiomyopathy
    Sreenivasan, Jayakumar
    Khan, Muhammad Shahzeb
    Kaul, Risheek
    Bandyopadhyay, Dhrubajyoti
    Hooda, Urvashi
    Aronow, Wilbert S.
    Cooper, Howard A.
    Panza, Julio A.
    Naidu, Srihari S.
    JACC-CARDIOVASCULAR INTERVENTIONS, 2021, 14 (08) : 930 - 932
  • [33] Septal Reduction Strategies in Hypertrophic Cardiomyopathy-The Scalpel, Catheter, or Wire?
    Bataiosu, Dana Roxana
    Rakowski, Harry
    JAMA CARDIOLOGY, 2022, 7 (05) : 538 - 539
  • [34] Benefit of Interventional Septal Reduction for Hypertrophic Cardiomyopathy: Looking for a Needle in a Haystack?
    Piot, Olivier
    Paziaud, Olivier
    Dreyfus, Julien
    ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES, 2024, 41 (10):
  • [35] Microvascular obstruction after nonsurgical septal reduction for the treatment of hypertrophic cardiomyopathy
    Wu, KC
    Heldman, AW
    Brinker, JA
    Hare, JM
    Lima, JAC
    CIRCULATION, 2001, 104 (15) : 1868 - 1868
  • [36] Long-term outcomes of septal reduction for obstructive hypertrophic cardiomyopathy
    Sedehi, Daniel
    Finocchiaro, Gherardo
    Tibayan, Yen
    Chi, Jeffrey
    Pavlovic, Aleksandra
    Kim, Young M.
    Tibayan, Frederick A.
    Reitz, Bruce A.
    Robbins, Robert C.
    Woo, Joseph
    Ha, Richard
    Lee, David P.
    Ashley, Euan A.
    JOURNAL OF CARDIOLOGY, 2015, 66 (1-2) : 57 - 62
  • [37] COVID-19 Impacted Septal Reduction Therapies in Hypertrophic Cardiomyopathy
    Desai, Spandan
    Roma, Nicholas
    Pattoli, Megan
    Durkin, Matthew
    Shah, Kashyap
    Amaratunga, Eluwana
    Magid, Lindsey
    Yellapu, Vikas
    Shirani, Jamshid
    CIRCULATION, 2024, 150
  • [38] Impact of Septal Reduction on Left Atrial Size and Diastole in Hypertrophic Cardiomyopathy
    Finocchiaro, Gherardo
    Haddad, Francois
    Kobayashi, Yukari
    Lee, David
    Pavlovic, Aleksandra
    Schnittger, Ingela
    Sinagra, Gianfranco
    Magavern, Emma
    Myers, Jonathan
    Froelicher, Victor
    Knowles, Joshua W.
    Ashley, Euan
    ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES, 2016, 33 (05): : 686 - 694
  • [39] Electrophysiologic consequences of nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy
    不详
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2000, 11 (11) : 1296 - 1296
  • [40] Symptomatic Obstructive Hypertrophic Cardiomyopathy
    Sorajja, Paul
    Ommen, Steve R.
    Nishimura, Rick A.
    CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2013, 6 (05) : 586 - 591
12345